These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 28471268)
1. Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter. Giesecke P; Rosenqvist M; Frykman V; Friberg L; Wallin G; Höijer J; Lönn S; Törring O Thyroid; 2017 Jul; 27(7):878-885. PubMed ID: 28471268 [TBL] [Abstract][Full Text] [Related]
2. Graves' disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study. Brandt F; Thvilum M; Almind D; Christensen K; Green A; Hegedüs L; Brix TH Thyroid; 2013 Apr; 23(4):408-13. PubMed ID: 23253072 [TBL] [Abstract][Full Text] [Related]
3. Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study. Cramon P; Winther KH; Watt T; Bonnema SJ; Bjorner JB; Ekholm O; Groenvold M; Hegedüs L; Feldt-Rasmussen U; Rasmussen ÅK Thyroid; 2016 Aug; 26(8):1010-8. PubMed ID: 27370744 [TBL] [Abstract][Full Text] [Related]
5. Graves' Disease and Toxic Nodular Goiter, Aggravated by Duration of Hyperthyroidism, Are Associated with Alzheimer's and Vascular Dementia: A Registry-Based Long-Term Follow-Up of Two Large Cohorts. Folkestad L; Brandt F; Lillevang-Johansen M; Brix TH; Hegedüs L Thyroid; 2020 May; 30(5):672-680. PubMed ID: 31984866 [No Abstract] [Full Text] [Related]
6. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism. Franklyn JA; Daykin J; Holder R; Sheppard MC QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667 [TBL] [Abstract][Full Text] [Related]
7. Familial risks for hospitalized Graves' disease and goiter. Hemminki K; Shu X; Li X; Ji J; Sundquist K; Sundquist J Eur J Endocrinol; 2009 Oct; 161(4):623-9. PubMed ID: 19661127 [TBL] [Abstract][Full Text] [Related]
8. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. Vestergaard P; Rejnmark L; Weeke J; Hoeck HC; Nielsen HK; Rungby J; Laurberg P; Mosekilde L Thyroid; 2002 Jan; 12(1):69-75. PubMed ID: 11838733 [TBL] [Abstract][Full Text] [Related]
9. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results]. Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510 [TBL] [Abstract][Full Text] [Related]
10. Total thyroidectomy: is morbidity higher for Graves' disease than nontoxic goiter? Welch KC; McHenry CR J Surg Res; 2011 Sep; 170(1):96-9. PubMed ID: 21550063 [TBL] [Abstract][Full Text] [Related]
11. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease. Martin NM; Patel M; Nijher GM; Misra S; Murphy E; Meeran K Clin Endocrinol (Oxf); 2012 Oct; 77(4):621-7. PubMed ID: 22443227 [TBL] [Abstract][Full Text] [Related]
15. Surgical management of hyperthyroidism. Quérat C; Germain N; Dumollard JM; Estour B; Peoc'h M; Prades JM Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Apr; 132(2):63-6. PubMed ID: 25592327 [TBL] [Abstract][Full Text] [Related]
16. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism]. Bürgi U; Gerber H; Peter HJ Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose]. Bakker SC; Zanin DE; Zweers EJ Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370 [TBL] [Abstract][Full Text] [Related]
18. Decreased birth weight, length, and head circumference in children born by women years after treatment for hyperthyroidism. Ohrling H; Törring O; Yin L; Iliadou AN; Tullgren O; Abraham-Nordling M; Wallin G; Hall P; Lönn S J Clin Endocrinol Metab; 2014 Sep; 99(9):3217-23. PubMed ID: 24878049 [TBL] [Abstract][Full Text] [Related]